Regulations Governing Internal Operating Systems and Procedures for Banks Conducting Financial Derivatives Business Article 7
A bank that has obtained approval to conduct financial derivatives business (approval must also be obtained in accordance with the Futures Trading Act if the business in question is futures trading business) may begin to offer financial derivatives and combinations thereof, provided that within fifteen (15) days after commencement of business it shall submit a description of each product's characteristics, a statement of regulatory compliance, and a risk disclosure statement to the Commission for reference. Notwithstanding the foregoing, the offering of the following products shall comply with the provisions of Paragraphs 2 ~ 5 hereof and Article 8 herein:1. Products involving contracts derived from either exchange-traded commodities or indexes related to domestic stock or futures exchanges other than equity derivatives linked to Taiwan stocks (referred to as "Taiwan equity-linked derivatives" hereunder).2. New types of Taiwan equity-linked derivatives.3. Complex high-risk products that are not yet deregulatedor have been deregulatedfor less than half a yearand are notforex-relatedoffered to customers other than professional institutional investors and high net worth corporate investors.4.Forex-related products that are required to file application with the Central Bank of the Republic of China (Taiwan) (called the "Central Bank" hereunder) for approval or to report to the Central Bank for recording..Once the Commission has granted approval to a bank to offer products under Subparagraph 1 of the preceding paragraph, other banks may proceed to offer the same type of products, provided the Commission does not raise any objection within ten (10) days from the next day following the date on which their application documents are delivered to the Commission. However, such a bank may not conduct the business under application until that 10-day period has elapsed.Once the Commission has granted approval to a bank to offer products under Subparagraph 2 of Paragraph 1 hereof, other banks may proceed to offer the same type of products, provided they submit relevant documents to the Commission for reference within fifteen (15) days from the date of commencement.Once the Commission has granted approval to a bank to offer a product under Subparagraph 3 of Paragraph 1 hereof and such product has been deregulated by the Commission for more than half a year, , other banks offering such product shall submit a letter with relevant documents to the Commission for recording within seven (7) days after conducting the first transaction and may proceed with the next transaction after receiving an approval letter from the Commission.A bank that intends to offer products under Subparagraph 4 of Paragraph 1 hereof shall directly file applications with the Central Bank for approval or report to the Central Bank for recording. Where the product is a forex-related complex high-risk product, the bank shall submit copies of applications to the Commission.
中文原文 銀行辦理衍生性金融商品業務內部作業制度及程序管理辦法第7條
銀行已取得辦理衍生性金融商品業務之核准者(其中屬辦理期貨商業務者,並應依期貨交易法之規定取得許可),得開辦各種衍生性金融商品及其商品之組合,並於開辦後十五日內檢附商品特性說明書、法規遵循聲明書及風險預告書報本會備查。
但下列商品應依第二項至第五項及第八條規定辦理:
一、除臺股股權衍生性金融商品外之其他涉及從事衍生自國內股價及期貨交易所有關之現貨商品及指數等契約。
二、新種臺股股權衍生性金融商品。
三、向專業機構投資人及高淨值投資法人以外客戶提供尚未開放或開放未滿半年且未涉及外匯之複雜性高風險商品。
四、涉及應向中央銀行申請許可或函報備查之外匯衍生性金融商品。
前項第一款商品,本會於核准第一家銀行辦理後,其他銀行於申請書件送達本會之次日起十日內,本會未表示反對意見者,即可逕行辦理。
但銀行不得於該十日期間內,辦理所申請之業務。
第一項第二款商品,本會於核准第一家銀行辦理後,其他銀行於開辦後十五日內檢附書件報本會備查。
第一項第三款商品,本會於核准第一家銀行辦理且開放已滿半年後,其他銀行於開辦首筆交易後七日內檢附書件報本會備查,並應俟收到本會同意備查函後,始得繼續辦理次筆交易。
第一項第四款商品,銀行逕向中央銀行申請許可或函報備查,屬涉及外匯之複雜性高風險商品,並應副知本會。
但下列商品應依第二項至第五項及第八條規定辦理:
一、除臺股股權衍生性金融商品外之其他涉及從事衍生自國內股價及期貨交易所有關之現貨商品及指數等契約。
二、新種臺股股權衍生性金融商品。
三、向專業機構投資人及高淨值投資法人以外客戶提供尚未開放或開放未滿半年且未涉及外匯之複雜性高風險商品。
四、涉及應向中央銀行申請許可或函報備查之外匯衍生性金融商品。
前項第一款商品,本會於核准第一家銀行辦理後,其他銀行於申請書件送達本會之次日起十日內,本會未表示反對意見者,即可逕行辦理。
但銀行不得於該十日期間內,辦理所申請之業務。
第一項第二款商品,本會於核准第一家銀行辦理後,其他銀行於開辦後十五日內檢附書件報本會備查。
第一項第三款商品,本會於核准第一家銀行辦理且開放已滿半年後,其他銀行於開辦首筆交易後七日內檢附書件報本會備查,並應俟收到本會同意備查函後,始得繼續辦理次筆交易。
第一項第四款商品,銀行逕向中央銀行申請許可或函報備查,屬涉及外匯之複雜性高風險商品,並應副知本會。